Number of the records: 1  

West nile virus and tick-borne encephalitis virus are endemic in equids in Eastern Austria

  1. 1.
    SYSNO ASEP0546079
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleWest nile virus and tick-borne encephalitis virus are endemic in equids in Eastern Austria
    Author(s) de Heus, P. (AT)
    Kolodziejek, J. (AT)
    Hubálek, Zdeněk (UBO-W) RID, SAI, ORCID
    Dimmel, K. (AT)
    Racher, V. (AT)
    Nowotny, N. (AT)
    Cavalleri, J.-M. V. (AT)
    Number of authors7
    Article number1873
    Source TitleViruses. - : MDPI
    Roč. 13, č. 9 (2021)
    Number of pages16 s.
    Languageeng - English
    CountryCH - Switzerland
    KeywordsAustria ; Epidemiology ; Flavivirus ; Horses ; Seroprevalence ; Tick-borne encephalitis virus ; Usutu virus ; West Nile virus
    Subject RIVEE - Microbiology, Virology
    OECD categoryVirology
    Method of publishingOpen access
    Institutional supportUBO-W - RVO:68081766
    UT WOS000702063000001
    EID SCOPUS85115372136
    DOI10.3390/v13091873
    AnnotationThe emergence of West Nile virus (WNV) and Usutu virus (USUV) in addition to the autochthonous tick-borne encephalitis virus (TBEV) in Europe causes rising concern for public and animal health. The first equine case of West Nile neuroinvasive disease in Austria was diagnosed in 2016. As a consequence, a cross-sectional seroprevalence study was conducted in 2017, including 348 equids from eastern Austria. Serum samples reactive by ELISA for either flavivirus immuno-globulin G or M were further analyzed with the plaque reduction neutralization test (PRNT-80) to identify the specific etiologic agent. Neutralizing antibody prevalences excluding vaccinated equids were found to be 5.3% for WNV, 15.5% for TBEV, 0% for USUV, and 1.2% for WNV from autoch-thonous origin. Additionally, reverse transcription quantitative polymerase chain reaction (RT-qPCR) was performed to detect WNV nucleic acid in horse sera and was found to be negative in all cases. Risk factor analysis did not identify any factors significantly associated with seropositivity.
    WorkplaceInstitute of Vertebrate Biology
    ContactHana Slabáková, slabakova@ivb.cz, Tel.: 543 422 524
    Year of Publishing2022
    Electronic addresshttps://www.mdpi.com/1999-4915/13/9/1873
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.